Laurus Technologies

Laurus Labs is a leading research-driven pharmaceutical and biotechnology company headquartered in Hyderabad, India. The company operates through four primary business segments: Generics API, Generics Finished Dosage Forms (FDF), Synthesis (CDMO), and Laurus Bio. It is a global leader in the production of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) drugs, supporting HIV treatment programs worldwide. Beyond its core API business, Laurus Labs has expanded into high-growth areas such as oncology, cardiovascular, and anti-diabetic therapeutics. The company also maintains a significant presence in the biotechnology sector through its subsidiary, Laurus Bio, which focuses on precision fermentation and recombinant proteins. Furthermore, Laurus Labs has made strategic investments in advanced therapies, notably partnering with ImmunoACT to commercialize CAR-T cell therapies in India.